Glucose Monitoring Global Market to Gain Traction to 2023, States IQ4I Research & Consultancy in Its New Study Available at MarketPublishers.com
23 Jun 2017 • by Natalie Aster
LONDON – Globally, the glucose monitoring global market is projected to see a single digit CAGR to reach USD 11,248.5 million by end-2023. The market is being driven by the global increase in the prevalence and incidence rates of diabetes, ongoing advances in technology, rising demand for minimally invasive products, and an upsurge in R&D investments.
Increased obesity rates owing to lifestyle changes, urbanisation growth, untapped markets such as the Middle East and Africa demonstrate that the glucose monitoring market has manifold opportunities in the years to come.
Meantime, frequent product recalls owing to production defects or supply of expired glucose testing strips and less differentiation amongst the self blood glucose monitoring equipment are some of the key restraints to the growth of the market. The major threats to the market’s expansion include the limited number of reimbursement facilities and alternative treatment modalities encompassing cell-based assays, biomarker identification and artificial pancreas (AP) and the expensiveness associated with continuous glucose monitoring (CGM).
Medtronic, Roche, Dexcom, Trividia Health, B. Braun Melsungen AG, AgaMatrix, Johnson & Johnson, Arkray, Abbott Laboratories, Ascensia, among others, are the prominent players in the market space.
New report “Glucose Monitoring Global Market - Forecast to 2023” elaborated by IQ4I Research & Consultancy provides an unprejudiced, deep analysis of the market performance across different regions such as APAC, North America, Europe and RoW.
It provides detailed market segmentation based on products, sample source, end-use sector, and by geography. The research publication gives access to relevant updated statistical figures and estimates, sheds light on the market trends and factors influencing the market. It casts light on the regulatory landscape, reimbursement scenario, upcoming technologies and product launches, clinical trial data, funding scenario, patients, supply chain, market shares of the players, etc. The report canvasses the competitive landscape and profiles the 11 dominant players. Additionally, the report provides a future outlook for the glucose monitoring market offering granular forecasts.
Many other new studies by the publisher are offered in the IQ4I Research & Consultancy catalogue.